Michael F. Price’s Teva Pharmaceuticals TEVA Stock Holding History

Michael F. Price’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-103,910	Closed	-$715K	–	126
2019 Q3	$715K	Sell	103,910 -965	-0.9%	-$7.39K	0.1%	89
2019 Q2	$968K	Hold	104,875	–	–	0.13%	86
2019 Q1	$1.64M	Hold	104,875	–	–	0.2%	74
2018 Q4	$1.62M	Hold	104,875	–	–	0.22%	74
2018 Q3	$2.26M	Hold	104,875	–	–	0.28%	65
2018 Q2	$2.55M	Hold	104,875	–	–	0.3%	63
2018 Q1	$1.79M	Hold	104,875	–	–	0.21%	75
2017 Q4	$1.99M	Buy	104,875 +50,000	+91%	+$752K	0.25%	72
2017 Q3	$966K	Sell	54,875 -665,125	-92%	-$15M	0.13%	80
2017 Q2	$23.9M	Hold	720,000	–	–	3.1%	8
2017 Q1	$23.1M	Buy	720,000 +23,500	+3%	+$802K	2.86%	8
2016 Q4	$25.2M	Buy	696,500 +227,200	+48%	+$9.07M	3.06%	7
2016 Q3	$21.6M	Buy	469,300 +29,000	+7%	+$1.51M	2.87%	7
2016 Q2	$22.1M	Hold	440,300	–	–	2.94%	7
2016 Q1	$23.6M	Hold	440,300	–	–	3.31%	6
2015 Q4	$28.9M	Hold	440,300	–	–	3.56%	6
2015 Q3	$24.9M	Hold	440,300	–	–	3.72%	5
2015 Q2	$26M	Hold	440,300	–	–	3.42%	7
2015 Q1	$27.4M	Sell	440,300 -7,200	-2%	-$419K	3.63%	7
2014 Q4	$25.7M	Sell	447,500 -52,500	-11%	-$2.92M	3.14%	9
2014 Q3	$26.9M	Hold	500,000	–	–	3.35%	7
2014 Q2	$26.2M	Buy	500,000 +111,600	+29%	+$5.7M	3.21%	6
2014 Q1	$20.5M	Sell	388,400 -11,600	-3%	-$536K	2.5%	12
2013 Q4	$16M	Buy	400,000 +50,000	+14%	+$1.97M	2.07%	22
2013 Q3	$13.2M	Hold	350,000	–	–	1.76%	22
2013 Q2	$13.7M	Buy	+350,000	New	+$13.6M	1.84%	21

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Michael F. Price's TEVA Position: Q4 2019 in Review

Michael F. Price sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 103,910 shares — an estimated $715K sold.

Michael F. Price first reported a position in TEVA in Q2 2013 and held it in 26 quarters. The position peaked at $28.9M in Q4 2015. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Michael F. Price reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Michael F. Price sold 103,910 Teva Pharmaceuticals shares in Q4 2019, an estimated $715K.
Michael F. Price first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 26 quarters.
Michael F. Price's Teva Pharmaceuticals position peaked at $28.9M in Q4 2015.
437 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Michael F. Price's 13F filing for Q4 2019, filed 14 Feb 2020.